Play all audios:
Access through your institution Buy or subscribe Fragoso-Loyo H _ et al_. (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
_Arthritis Rheum_ 56: 1242–1250 Patients with systemic lupus erythematosus (SLE) can have a wide array of neuropsychiatric manifestations, but despite the high prevalence of these
manifestations, an accurate indicator of central nervous system involvement in patients with SLE has not been identified. Cytokines and chemokines are associated with neuropsychiatric
symptoms, and therefore a study has been carried out to elucidate the levels of inflammatory molecules in the cerebrospinal fluid (CSF) of patients with neuropsychiatric SLE. This is a
preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per
year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated
during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT
THIS ARTICLE CITE THIS ARTICLE Potential role of interleukin-6 and chemokines in the pathogenesis of neuropsychiatric SLE. _Nat Rev Rheumatol_ 3, 369 (2007).
https://doi.org/10.1038/ncprheum0521 Download citation * Issue Date: July 2007 * DOI: https://doi.org/10.1038/ncprheum0521 SHARE THIS ARTICLE Anyone you share the following link with will be
able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing
initiative